WASHINGTON (MedPage Today) — Sen. Max Baucus (D-Mont.) on Friday said he would introduce a bill to repeal an unpopular provision in the healthcare reform law that requires employers to fill out a 1099 tax form every time they spend $600 on goods and services.
No Comments »
Filed under: General Health News
(MedPage Today) — Energizing lazy eyes, how BPA affects human reproduction, immunizing against UTI, and promising but early studies in rheumatology highlight this week’s Lab Notes.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA has granted an appeal for a personalized sedation device that it rejected earlier this year.
No Comments »
Filed under: General Health News
(MedPage Today) — Physician and patient participation in accountable care organizations (ACOs) should be voluntary, according to a new policy adopted by the American Medical Association.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — FDA reviewers are questioning whether the “somewhat marginal efficacy” of a novel rheumatoid arthritis drug with blockbuster potential outweighs the biologic’s possible risk of infection, cancer, and suicide.
No Comments »
Filed under: General Health News
Threshold Pharmaceuticals, Inc. today announced clinical trial results related to Threshold’s clinical stage hypoxia-activated prodrug, TH-302. The results were presented at the 16th Annual Connective Tissue Oncology Society (CTOS) Meeting taking place in Paris, France from November 11 to 13, 2010.
No Comments »
Filed under: Pharmacy News
Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for therapeutics for cardiovascular disease, today announced its third quarter financial results for 2010.
No Comments »
Filed under: Pharmacy News
Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today reported its financial results for the third quarter and the nine months ended September 30, 2010. These results are included in the Company’s Quarterly Report on Form 10-Q, which has been filed with the SEC.
No Comments »
Filed under: Pharmacy News
Results of two pre-specified sub-study analyses of the 18,113 patient RE-LY trial, involving the newly approved oral anticoagulant Pradaxa (dabigatran etexilate mesylate) capsules, will be presented at the American Heart Association’s Annual Scientific Sessions on Monday, November 15, 2010.
No Comments »
Filed under: Pharmacy News
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Dr. Spyros Kalams will provide an update of interim immune responses and safety results from the HVTN 080 Phase I clinical study of Inovio’s PENNVAX-B HIV DNA vaccine in a preventive setting.
No Comments »
Filed under: Pharmacy News
